Faculty profile

Guojun Chen

ResearcherBiomedical EngineeringMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.

Guojun Chen

Researcher

Biomedical Engineering

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
28 publications in the last five years, latest in 2027.
Senior (last) author on 13 recent papers, a sign of leading a research group.
Principal investigator on 7 research grants (4 NSERC, 3 CIHR), most recently in 2024.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Drug Delivery Biomaterials Cold Atmospheric Plasma Combined Therapy Hydrogel Immune Checkpoint Blockade Triple Negative Breast Cancer Cancer Immunotherapy

Latest papers

Corrigendum to "Self-intensified synergy of a versatile biomimetic nanozyme and doxorubicin on electrospun fibers to inhibit postsurgical tumor recurrence and metastasis" [Biomaterials 293 (2023) 121942].
Biomaterials · 2027
Lyophilized bacteria-infected tumor cells for targeted immunotherapy of lung metastases and associated fibrosis.
Bioactive materials · 2026 · senior author
Cold Atmospheric Plasma-Activated Decellularized Extracellular Matrix Gel as a Tumor-Infiltrating Immunoactivation Platform for Post-Surgical Cancer Immunotherapy.
Advanced materials (Deerfield Beach, Fla.) · 2026 · senior author

All 32 publications

Latest funding

Curing HIV-1 reservoir cells by targeted delivery of CRISPR
CIHR · 2024 · Co-investigator
$200,000
A histology platform to visualize cells, tissues and organs across living systems
NSERC · 2024 · Co-investigator
$97,880
Bioresponsive Immunomodulator Nanocomplex for Selective Immunoengineering to Treat Lymph Node Metastasis
CIHR · 2024 · Nominated PI
$826,200

All 11 grants and awards

32 publications.

Corrigendum to "Self-intensified synergy of a versatile biomimetic nanozyme and doxorubicin on electrospun fibers to inhibit postsurgical tumor recurrence and metastasis" [Biomaterials 293 (2023) 121942].

Hu Y, Xu Y, Mintz RL, Luo X, Fang Y, Lao YH, Chan HF, Li K, Lv S, Chen G, Tao Y, Luo Y, Li M

Biomaterials2027

DOI: 10.1016/j.biomaterials.2026.124515 PMID: 42567740

Lyophilized bacteria-infected tumor cells for targeted immunotherapy of lung metastases and associated fibrosis.

Chen M, Deng Y, Fang T, Luo T, Chen G

Bioactive materials2026Senior author

DOI: 10.1016/j.bioactmat.2026.05.044 PMID: 42256887

Cold Atmospheric Plasma-Activated Decellularized Extracellular Matrix Gel as a Tumor-Infiltrating Immunoactivation Platform for Post-Surgical Cancer Immunotherapy.

Fang T, Chen M, Deng Y, Ning T, Luo T, Chen G

Advanced materials (Deerfield Beach, Fla.)2026Senior author

DOI: 10.1002/adma.202515444 PMID: 41821382

PTPN1/PTPN2 inhibition improves NK cancer therapy by enhancing IL-2 and mitigating TGFβ1 responses.

Feng CH, Peltier L, Chouleur T, DiPonzio M, Aubry I, Poirier AJ, Cordova ZM, Shen Y, Tabariès S, Cao X, Chen G, Bikfalvi A, Vidal SM, Siegel PM, Laneuville P, Tremblay ML

EMBO reports2026

DOI: 10.1038/s44319-026-00745-0 PMID: 41986797

Sprayed low-temperature plasma-infused hydrogel dressing for skin-wound management.

Chen M, Fang Q, Shen B, Deng Y, Ning T, Huang Y, Cao F, Chen Z, Chen Z, Chen G

Med (New York, N.Y.)2026Senior author

DOI: 10.1016/j.medj.2025.100935 PMID: 41443198

Microliter-scale ethanol confinement array with biofluidic triggered release for dual-enhanced precision chemotherapy.

Ma T, Zhang F, Pan Y, Li Z, Wang Y, Wang J, Chen G, Wang Z

Biomaterials2026

DOI: 10.1016/j.biomaterials.2025.123577 PMID: 40752287

Bioresponsive immunomodulator nanocomplex for selective immunoengineering in metastatic lymph nodes.

Deng Y, Chen M, Fang T, Luo T, Cao X, Chen G

Proceedings of the National Academy of Sciences of the United States of America2026Senior author

DOI: 10.1073/pnas.2519625123 PMID: 41557810

Nanoparticles-mediated intratumoral gene editing targeting PD-L1 and Galectin-9 for improved cancer immunotherapy.

Fang T, Deng Y, Chen M, Luo T, Ning T, Chen G

Biomaterials2026Senior author

DOI: 10.1016/j.biomaterials.2025.123511 PMID: 40570715

Advances in cold atmospheric plasma therapy for cancer.

Fang T, Chen Z, Chen G

Bioactive materials2025Senior author

DOI: 10.1016/j.bioactmat.2025.07.031 PMID: 40747454

Cold atmospheric plasma as a novel "drug" for cancer therapy.

Fu D, Lin S, Xu Q, Cao F, Khan I, Xu S, Li Z, Chen Z, Fang Q, Chen G, Wang Z, Chen Z

Journal of controlled release : official journal of the Controlled Release Society2025

DOI: 10.1016/j.jconrel.2025.114118 PMID: 40803446

Curing HIV-1 reservoir cells by targeted delivery of CRISPR

Co-investigatorCIHR2024Ca. Gr.: Biomedical Res. for HIV/AIDS/STBBI -Next-gen. therapeutic interventions

Principal investigators: Liang, Chen

Keywords: Crispr Gene Editing; Hiv/Aids; Lnps; Reservoirs; Targeted Delivery

$200,000

A histology platform to visualize cells, tissues and organs across living systems

Co-investigatorNSERC2024Research Tools and Instruments

Principal investigators: Cockburn, Katherine

Keywords: Animal models; Biomedical engineering; Cell biology; Cell morphology; Gene expression; Histology; Materials science; Tissue architecture; Tissue sectioning

$97,880

Bioresponsive Immunomodulator Nanocomplex for Selective Immunoengineering to Treat Lymph Node Metastasis

Nominated PICIHR2024Project Grant

Principal investigators: Chen, Guojun

Keywords: Cancer Immunotherapy; Drug Delivery; Immunoengineering; Lymph Node Metastasis; Nanomedicine; Nanotechnolgy

$826,200

Biomaterials and Biomacromolecule Delivery

Principal investigatorNSERC2023Canada Research Chairs

Principal investigators: Chen, Guojun

Keywords: Biomaterials; Biomacromolecules; Drug delivery; Nanotechnology; Materials Science; Gene delivery; Nanomaterials

$165,000

Quantification of physical and chemical characteristics of cells and bioparticles using flow cytometry

Co-investigatorNSERC2022Research Tools and Instruments

Principal investigators: Tabrizian, Maryam

$59,829

Engineering injectable cold atmospheric plasma-preserved hydrogel to treat breast cancer

Nominated PICIHR2022Project Grant

Principal investigators: Chen, Guojun

Keywords: Biomaterials; Cold Atmospheric Plasma; Combined Therapy; Drug Delivery; Hydrogel; Immune Checkpoint Blockade; Triple Negative Breast Cancer

$787,950

Probing and imaging cellular and molecular event dynamics at the interface using atomic force microscopy

Co-investigatorNSERC2021Research Tools and Instruments

Principal investigators: Tabrizian, Maryam

$66,515

Engineering Controllable Non-Viral Systems for Efficient and Precise CRISPR/Cas9 Delivery

Principal investigatorNSERC2021Discovery Grants Program - Individual

Principal investigators: Chen, Guojun

$116,000

Engineering injectable cold atmospheric plasma-preserved hydrogel to treat breast cancer

Nominated PICIHR2021Project Grant - PA: Breast Cancer Research

Principal investigators: Chen, Guojun

Keywords: Biomaterials; Cold Atmospheric Plasma; Combined Therapy; Drug Delivery; Hydrogel; Immune Checkpoint Blockade; Triple Negative Breast Cancer

$100,000

Engineering Next-Generation Nanoformulations for Bioresponsive CRISPR/Cas9 Delivery

Principal investigatorNSERC2021Alliance Grants

Principal investigators: Chen, Guojun

$135,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2024

Subject: Prospective PhD student: Drug Delivery Dear Professor Chen, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Corrigendum to "Self-intensified synergy of a versatile biomimetic nanozyme and doxorubicin on electrospun fibers to inhibit postsurgical tumor recurrence and metastasis" [Biomaterials 293 (2023) 121942]." (2027), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Bioresponsive Immunomodulator Nanocomplex for Selective Immunoengineering to Treat Lymph Node Metastasis" (2024), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Guojun Chen

Research

Latest papers

Latest funding

Corrigendum to "Self-intensified synergy of a versatile biomimetic nanozyme and doxorubicin on electrospun fibers to inhibit postsurgical tumor recurrence and metastasis" [Biomaterials 293 (2023) 121942].

Lyophilized bacteria-infected tumor cells for targeted immunotherapy of lung metastases and associated fibrosis.

Cold Atmospheric Plasma-Activated Decellularized Extracellular Matrix Gel as a Tumor-Infiltrating Immunoactivation Platform for Post-Surgical Cancer Immunotherapy.

PTPN1/PTPN2 inhibition improves NK cancer therapy by enhancing IL-2 and mitigating TGFβ1 responses.

Sprayed low-temperature plasma-infused hydrogel dressing for skin-wound management.

Microliter-scale ethanol confinement array with biofluidic triggered release for dual-enhanced precision chemotherapy.

Bioresponsive immunomodulator nanocomplex for selective immunoengineering in metastatic lymph nodes.

Nanoparticles-mediated intratumoral gene editing targeting PD-L1 and Galectin-9 for improved cancer immunotherapy.

Advances in cold atmospheric plasma therapy for cancer.

Cold atmospheric plasma as a novel "drug" for cancer therapy.

Curing HIV-1 reservoir cells by targeted delivery of CRISPR

A histology platform to visualize cells, tissues and organs across living systems

Bioresponsive Immunomodulator Nanocomplex for Selective Immunoengineering to Treat Lymph Node Metastasis

Biomaterials and Biomacromolecule Delivery

Quantification of physical and chemical characteristics of cells and bioparticles using flow cytometry

Engineering injectable cold atmospheric plasma-preserved hydrogel to treat breast cancer

Probing and imaging cellular and molecular event dynamics at the interface using atomic force microscopy

Engineering Controllable Non-Viral Systems for Efficient and Precise CRISPR/Cas9 Delivery

Engineering injectable cold atmospheric plasma-preserved hydrogel to treat breast cancer

Engineering Next-Generation Nanoformulations for Bioresponsive CRISPR/Cas9 Delivery

Frequent collaborators

Morag Park

Morag Park

Jianyu Li

Sidong Huang

Lisbet Haglund

David Dankort

Guojun Chen

Research

Latest papers

Latest funding

Corrigendum to "Self-intensified synergy of a versatile biomimetic nanozyme and doxorubicin on electrospun fibers to inhibit postsurgical tumor recurrence and metastasis" [Biomaterials 293 (2023) 121942].

Lyophilized bacteria-infected tumor cells for targeted immunotherapy of lung metastases and associated fibrosis.

Cold Atmospheric Plasma-Activated Decellularized Extracellular Matrix Gel as a Tumor-Infiltrating Immunoactivation Platform for Post-Surgical Cancer Immunotherapy.

PTPN1/PTPN2 inhibition improves NK cancer therapy by enhancing IL-2 and mitigating TGF&#x3b2;1 responses.

Sprayed low-temperature plasma-infused hydrogel dressing for skin-wound management.

Microliter-scale ethanol confinement array with biofluidic triggered release for dual-enhanced precision chemotherapy.

Bioresponsive immunomodulator nanocomplex for selective immunoengineering in metastatic lymph nodes.

Nanoparticles-mediated intratumoral gene editing targeting PD-L1 and Galectin-9 for improved cancer immunotherapy.

Advances in cold atmospheric plasma therapy for cancer.

Cold atmospheric plasma as a novel "drug" for cancer therapy.

Curing HIV-1 reservoir cells by targeted delivery of CRISPR

A histology platform to visualize cells, tissues and organs across living systems

Bioresponsive Immunomodulator Nanocomplex for Selective Immunoengineering to Treat Lymph Node Metastasis

Biomaterials and Biomacromolecule Delivery

Quantification of physical and chemical characteristics of cells and bioparticles using flow cytometry

Engineering injectable cold atmospheric plasma-preserved hydrogel to treat breast cancer

Probing and imaging cellular and molecular event dynamics at the interface using atomic force microscopy

Engineering Controllable Non-Viral Systems for Efficient and Precise CRISPR/Cas9 Delivery

Engineering injectable cold atmospheric plasma-preserved hydrogel to treat breast cancer

Engineering Next-Generation Nanoformulations for Bioresponsive CRISPR/Cas9 Delivery

Frequent collaborators

Morag Park

Morag Park

Jianyu Li

Sidong Huang

Lisbet Haglund

David Dankort

PTPN1/PTPN2 inhibition improves NK cancer therapy by enhancing IL-2 and mitigating TGFβ1 responses.